These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33496103)

  • 21. [Effects of doubled CO2 concentration on Erigeron breviscapus growth and its active constituent accumulation].
    Li XH; Su WH; Zhou H; Zhang GF
    Ying Yong Sheng Tai Xue Bao; 2009 Aug; 20(8):1852-6. PubMed ID: 19947202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Separation of scutellarin from crude extracts of Erigeron breviscapus (vant.) Hand. Mazz. by macroporous resins.
    Gao M; Huang W; Liu CZ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):22-6. PubMed ID: 17704013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis.
    Hu X; Teng S; He J; Sun X; Du M; Kou L; Wang X
    Mol Med Rep; 2018 Nov; 18(5):4289-4296. PubMed ID: 30221730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research progress and strategy on genetic improvement of Erigeron breviscapus].
    Zhang W; Yang SC; Zhang GH; Su B
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(14):2250-3. PubMed ID: 24199549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research on situation and countermeasure of Erigeron breviscapus plant production].
    Zhang W; Yang SC; Zhang GH; Su B
    Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(14):2227-30. PubMed ID: 24199544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease.
    Kumar S; Srivastav S; Fatima M; Giri RS; Mandal B; Mondal AC
    J Alzheimers Dis; 2019; 69(2):499-512. PubMed ID: 30958369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemical constituents from herbs of Erigeron breviscapus].
    Li J; Yu D
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1458-62. PubMed ID: 22779177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease.
    Kar S; Slowikowski SP; Westaway D; Mount HT
    J Psychiatry Neurosci; 2004 Nov; 29(6):427-41. PubMed ID: 15644984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on optimal harvest time of Erigeron breviscapus].
    Yang SC; Zhang XF; Zhang LM; Liu LX; Yang YJ; Xiao FH
    Zhongguo Zhong Yao Za Zhi; 2008 Dec; 33(23):2744-6. PubMed ID: 19260301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect on multifocal electroretinogram in persistently elevated intraocular pressure by erigeron breviscapus extract.
    Lu XJ; Zhang FW; Cheng L; Liu AQ; Duan JG
    Int J Ophthalmol; 2011; 4(4):349-52. PubMed ID: 22553678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of free radical scavengers from Erigeron breviscapus using on-line HPLC-ABTS/DPPH based assay and mass spectrometer detection.
    Li F; Zhang LD; Li BC; Yang J; Yu H; Wan JB; Wang YT; Li P
    Free Radic Res; 2012 Mar; 46(3):286-94. PubMed ID: 22239535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-level laser therapy for beta amyloid toxicity in rat hippocampus.
    Lu Y; Wang R; Dong Y; Tucker D; Zhao N; Ahmed ME; Zhu L; Liu TC; Cohen RM; Zhang Q
    Neurobiol Aging; 2017 Jan; 49():165-182. PubMed ID: 27815990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of
    Zhu J; Chen L; Qi Y; Feng J; Zhu L; Bai Y; Wu H
    Mol Vis; 2018; 24():315-325. PubMed ID: 29769797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artemether Activation of AMPK/GSK3
    Li S; Zhao X; Lazarovici P; Zheng W
    Oxid Med Cell Longev; 2019; 2019():1862437. PubMed ID: 31871541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in the treatment of Alzheimer's disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors.
    Kuo YC; Rajesh R
    Expert Rev Neurother; 2019 Jul; 19(7):623-652. PubMed ID: 31109210
    [No Abstract]   [Full Text] [Related]  

  • 39. Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells.
    Zeng KW; Ko H; Yang HO; Wang XM
    Neuropharmacology; 2010 Nov; 59(6):542-50. PubMed ID: 20708632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A UHPLC-MS/MS method for simultaneous determination of twelve constituents from Erigeron breviscapus extract in rat plasma: Application to a pharmacokinetic study.
    Tian Y; Li Q; Zhou X; Pang Q; Xu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():1-12. PubMed ID: 28126442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.